MannKind Corporation to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
September 02, 2016 17:00 ET
|
MannKind
VALENCIA, Calif., Sept. 02, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced today that the Company will present at the Rodman & Renshaw 18th Annual Global...
Securities Class Action Against MannKind Dismissed
August 25, 2016 09:00 ET
|
MannKind
VALENCIA, Calif., Aug. 25, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced that the United States District Court for the Central District of California has...
MannKind Corporation Reports 2016 Second Quarter Financial Results
August 08, 2016 16:00 ET
|
MannKind
VALENCIA, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today reported financial results for the second quarter and the six months ended June 30, 2016.For...
MannKind Corporation to Hold 2016 Second Quarter Financial Results Conference Call on August 8, 2016
August 01, 2016 17:00 ET
|
MannKind
VALENCIA, Calif., Aug. 01, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) will release its 2016 second quarter financial results on Monday, August 8, 2016 and its...
Mannkind Assumes Responsibility for Distribution of Afrezza® and Launches Patient Reimbursement and Adherence Support Programs
August 01, 2016 09:00 ET
|
MannKind
VALENCIA, Calif., Aug. 01, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced it is now distributing MannKind-branded Afrezza® (insulin human) Inhalation Powder...
MannKind Corporation to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
July 08, 2016 17:00 ET
|
MannKind
VALENCIA, Calif., July 08, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced today that the Company will present at Cantor Fitzgerald’s 2nd Annual Healthcare...
MannKind Announces Late-Breaking Data Reinforcing Faster Onset and Shorter Duration of Action Compared to Mealtime Insulins
June 12, 2016 15:00 ET
|
MannKind
Data presented at ADA show Afrezza has a 25-to 35-minute faster onset of action than Lispro, with a duration that is up to two hours shorter MannKind Corporation reaffirms commitment to...
MannKind Announces Collaboration with JDRF
June 10, 2016 09:00 ET
|
MannKind
VALENCIA, Calif., June 10, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced today that it has entered into a collaboration agreement with JDRF (formerly known as...
MannKind Announces Pricing of Registered Direct Public Offering of Common Stock and Warrants
May 09, 2016 18:23 ET
|
MannKind
VALENCIA, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today announced the pricing of a registered direct public offering of up to 48,543,692 shares of...
MannKind Corporation Reports 2016 First Quarter Financial Results
May 09, 2016 16:00 ET
|
MannKind
VALENCIA, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today reported financial results for the first quarter ended March 31, 2016.For the first quarter of...